|
87
|
324
|
5canA |
Egfr kinase domain mutant "tmlr" with compound 27 |
|
90
|
324
|
5c8nA |
Egfr kinase domain mutant "tmlr" with compound 23 |
|
91
|
323
|
5cauA |
Egfr kinase domain mutant "tmlr" with compound 41b |
|
94
|
309
|
5fdpA |
Structure of ddr1 receptor tyrosine kinase in complex with d2099 inhibitor at 2.25 angstroms resolution. |
|
94
|
322
|
5caqA |
Egfr kinase domain mutant "tmlr" with compound 33 |
|
91
|
323
|
5capA |
Egfr kinase domain mutant "tmlr" with compound 30 |
|
88
|
324
|
5cavA |
Egfr kinase domain with compound 41a |
|
83
|
323
|
5caoA |
Egfr kinase domain mutant "tmlr" with compound 29 |
|
91
|
308
|
5bvnA |
Fragment-based discovery of potent and selective ddr1/2 inhibitors |
|
95
|
322
|
5c8kA |
Egfr kinase domain mutant "tmlr" with compound 1 |
|
92
|
308
|
5bvoA |
Fragment-based discovery of potent and selective ddr1/2 inhibitors |
|
90
|
300
|
5b7vA |
Human fgfr1 kinase in complex with ch5183284 |
|
97
|
309
|
5aa8A |
Structure of c1156y,l1198f mutant human anaplastic lymphoma kinase in complex with pf-06463922 ((10r)-7-amino-12-fluoro-2,10,16-trimethyl- 15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). |
|
19
|
95
|
5abdE |
Crystal structure of vegfr-1 domain 2 in presence of cu |
|
98
|
309
|
5a9uA |
Structure of c1156y mutant human anaplastic lymphoma kinase in complex with pf-06463922 ((10r)-7-amino-12-fluoro-2,10,16-trimethyl- 15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). |
|
100
|
309
|
5aa9A |
Structure of l1198f mutant human anaplastic lymphoma kinase in complex with pf-06463922 ((10r)-7-amino-12-fluoro-2,10,16-trimethyl- 15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). |
|
98
|
308
|
5aaaA |
Structure of l1198f mutant human anaplastic lymphoma kinase in complex with crizotinib |
|
98
|
309
|
5aacA |
Structure of c1156y mutant human anaplastic lymphoma kinase in complex with crizotinib |
|
97
|
309
|
5aabA |
Structure of c1156y,l1198f mutant human anaplastic lymphoma kinase in complex with crizotinib |
|
88
|
302
|
5a4cA |
Fgfr1 ligand complex |
|
86
|
302
|
5a46A |
Fgfr1 in complex with dovitinib |
|
94
|
301
|
4zsaA |
Crystal structure of fgfr1 kinase domain in complex with 7n |
|
86
|
283
|
4zjvA |
Crystal structure of egfr kinase domain in complex with mitogen-inducible gene 6 protein |
|
81
|
320
|
4zauA |
Azd9291 complex with wild type egfr |
|
102
|
307
|
4z55A |
Anaplastic lymphoma kinase catalytic domain complexed with pyrazolopyrimidine derivative of ldk378 |
|
61
|
186
|
4z64C |
The plant peptide hormone receptor complex in arabidopsis |
|
89
|
291
|
4ymjA |
(r)-2-phenylpyrrolidine substitute imidazopyridazines: a new class of potent and selective pan-trk inhibitors |
|
242
|
743
|
4lsaA |
Crystal structure of bri1 sud1 (gly643glu) bound to brassinolide |
|
216
|
740
|
4lsxA |
Plant steroid receptor ectodomain bound to brassinolide and serk1 co-receptor ectodomain |
|
88
|
299
|
4f64A |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with compound 6 |
|
90
|
297
|
4qqtA |
Crystal structure of fgf receptor (fgfr) 4 tyrosine kinase domain |
|
93
|
290
|
4f0iA |
Crystal structure of apo trka |
|
88
|
299
|
4f63A |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with compound 1 |
|
34
|
175
|
4m7eC |
Structural insight into bl-induced activation of the bri1-bak1 complex |
|
87
|
302
|
4f65A |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with compound 8 |
|
91
|
291
|
4pmpA |
The structure of trka kinase bound to the inhibitor 1-cyclopropyl-1-[3-(1,3-thiazol-2-yl)benzyl]-3-[4-(trifluoromethoxy)phenyl]urea |
|
46
|
185
|
4lsxC |
Plant steroid receptor ectodomain bound to brassinolide and serk1 co-receptor ectodomain |
|
94
|
303
|
4hw7A |
Crystal structure of fms kinase domain with a small molecular inhibitor, plx647-ome |
|
42
|
175
|
4mn8B |
Crystal structure of flg22 in complex with the fls2 and bak1 ectodomains |
|
104
|
326
|
4hvsA |
Crystal structure of kit kinase domain with a small molecule inhibitor, plx647 |
|
36
|
283
|
4expX |
Structure of mouse interleukin-34 in complex with mouse fms |
|
214
|
733
|
4m7eA |
Structural insight into bl-induced activation of the bri1-bak1 complex |
|
25
|
174
|
4et7A |
Crystal structure of eph receptor 5 |
|
84
|
302
|
4eevA |
Crystal structure of c-met in complex with ly2801653 |
|
39
|
276
|
4dkdC |
Crystal structure of human interleukin-34 bound to human csf-1r |
|
87
|
294
|
4deiA |
Crystal structure of c-met in complex with triazolopyridinone inhibitor 24 |
|
98
|
309
|
4ctbA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor (5r)-8-amino-3-fluoro-5,19-dimethyl-20-oxo-5,18,19,20- tetrahydro-7,11-(azeno)pyrido(2',1':2,3)imidazo(4,5-h)(2,5,11) benzoxadiazacyclotetradecine-14-carbonitrile |
|
87
|
294
|
4dehA |
Crystal structure of c-met in complex with triazolopyridinone inhibitor 3 |
|
21
|
94
|
4ckvX |
Crystal structure of vegfr-1 domain 2 in presence of zn |
|
92
|
308
|
4ctcA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 7-amino-3-cyclopropyl-12-fluoro-1,10,16-trimethyl-16,17- dihydro-1h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecin-15(10h)-one |
